229 related articles for article (PubMed ID: 32720161)
1. HIV-Associated Neurocognitive Disorder (HAND): Relative Risk Factors.
Kompella S; Al-Khateeb T; Riaz OA; Orimaye SO; Sodeke PO; Awujoola AO; Ikekwere J; Goodkin K
Curr Top Behav Neurosci; 2021; 50():401-426. PubMed ID: 32720161
[TBL] [Abstract][Full Text] [Related]
2. Prevalence and 1-year incidence of HIV-associated neurocognitive disorder (HAND) in adults aged ≥50 years attending standard HIV clinical care in Kilimanjaro, Tanzania.
Flatt A; Gentry T; Kellett-Wright J; Eaton P; Joseph M; Urasa S; Howlett W; Dekker M; Kisoli A; Rogathe J; Henderson L; Lewis T; Thornton J; McCartney J; Yarwood V; Irwin C; Mukaetova-Ladinska EB; Akinyemi R; Gray WK; Walker RW; Dotchin CL; Quaker AS; Makupa PC; Paddick SM
Int Psychogeriatr; 2023 Jul; 35(7):339-350. PubMed ID: 33757616
[TBL] [Abstract][Full Text] [Related]
3. Aging, comorbidities, and the importance of finding biomarkers for HIV-associated neurocognitive disorders.
Rosenthal J; Tyor W
J Neurovirol; 2019 Oct; 25(5):673-685. PubMed ID: 30868422
[TBL] [Abstract][Full Text] [Related]
4. Association Between Frailty and HIV-Associated Neurodegenerative Disorders Among Older Adults Living with HIV.
Zamudio-Rodríguez A; Belaunzarán-Zamudio PF; Sierra-Madero JG; Cuellar-Rodríguez J; Crabtree-Ramírez BE; Alcala-Zermeno JL; Amieva H; Avila-Funes JA
AIDS Res Hum Retroviruses; 2018 May; 34(5):449-455. PubMed ID: 29385834
[TBL] [Abstract][Full Text] [Related]
5. Vascular cognitive impairment and HIV-associated neurocognitive disorder: a new paradigm.
Cysique LA; Brew BJ
J Neurovirol; 2019 Oct; 25(5):710-721. PubMed ID: 30635846
[TBL] [Abstract][Full Text] [Related]
6. HIV-Associated Neurocognitive Disorders: The First Longitudinal Follow-Up of a cART-Treated Cohort of Older People in Sub-Saharan Africa.
Spooner R; Ranasinghe S; Urasa S; Yoseph M; Koipapi S; Mukaetova-Ladinska EB; Lewis T; Howlett W; Dekker M; Kisoli A; Gray WK; Walker RW; Dotchin CL; Kalaria R; Lwezuala B; Makupa PC; Akinyemi R; Paddick SM
J Acquir Immune Defic Syndr; 2022 Jun; 90(2):214-222. PubMed ID: 35125473
[TBL] [Abstract][Full Text] [Related]
7. HIV-associated neurocognitive disorders at Moi teaching and referral hospital, Eldoret, Kenya.
Mohamed AA; Oduor C; Kinyanjui D
BMC Neurol; 2020 Jul; 20(1):280. PubMed ID: 32664858
[TBL] [Abstract][Full Text] [Related]
8. The road to success. Long-term prognosis for persons living with HIV in Denmark - time trends and risk factors.
Lohse N
Dan Med J; 2016 Feb; 63(2):. PubMed ID: 26836803
[TBL] [Abstract][Full Text] [Related]
9. Low incidence of advanced neurological burden but high incidence of age-related conditions that are dementia risk factors in aging people living with HIV: a data-linkage 10-year follow-up study.
Aung HL; Bloch M; Vincent T; Mao L; Brew BJ; Cysique LA
J Neurovirol; 2023 Apr; 29(2):141-155. PubMed ID: 36508059
[TBL] [Abstract][Full Text] [Related]
10. Aging and Apolipoprotein E in HIV Infection.
Geffin R; McCarthy M
J Neurovirol; 2018 Oct; 24(5):529-548. PubMed ID: 29987582
[TBL] [Abstract][Full Text] [Related]
11. Screening HIV-associated neurocognitive disorders (HAND) among HIV positive patients attending antiretroviral therapy in South Wollo, Ethiopia.
Tsegaw M; Andargie G; Alem G; Tareke M
J Psychiatr Res; 2017 Feb; 85():37-41. PubMed ID: 27821271
[TBL] [Abstract][Full Text] [Related]
12. Global prevalence and burden of HIV-associated neurocognitive disorder: A meta-analysis.
Wang Y; Liu M; Lu Q; Farrell M; Lappin JM; Shi J; Lu L; Bao Y
Neurology; 2020 Nov; 95(19):e2610-e2621. PubMed ID: 32887786
[TBL] [Abstract][Full Text] [Related]
13. The burden of HIV-associated neurocognitive impairment in Australia and its estimates for the future.
Cysique LA; Bain MP; Brew BJ; Murray JM
Sex Health; 2011 Dec; 8(4):541-50. PubMed ID: 22127041
[TBL] [Abstract][Full Text] [Related]
14. Anemia and Red Blood Cell Indices Predict HIV-Associated Neurocognitive Impairment in the Highly Active Antiretroviral Therapy Era.
Kallianpur AR; Wang Q; Jia P; Hulgan T; Zhao Z; Letendre SL; Ellis RJ; Heaton RK; Franklin DR; Barnholtz-Sloan J; Collier AC; Marra CM; Clifford DB; Gelman BB; McArthur JC; Morgello S; Simpson DM; McCutchan JA; Grant I;
J Infect Dis; 2016 Apr; 213(7):1065-73. PubMed ID: 26690344
[TBL] [Abstract][Full Text] [Related]
15. Machine learning models reveal neurocognitive impairment type and prevalence are associated with distinct variables in HIV/AIDS.
Tu W; Chen PA; Koenig N; Gomez D; Fujiwara E; Gill MJ; Kong L; Power C
J Neurovirol; 2020 Feb; 26(1):41-51. PubMed ID: 31520320
[TBL] [Abstract][Full Text] [Related]
16. Neuropsychological Assessment of 412 HIV-Infected Individuals in São Paulo, Brazil.
Gascón MRP; Vidal JE; Mazzaro YM; Smid J; Marcusso RMN; Capitão CG; Coutinho EM; Benute GRG; De Lucia MCS; de Oliveira ACP
AIDS Patient Care STDS; 2018 Jan; 32(1):1-8. PubMed ID: 29323557
[TBL] [Abstract][Full Text] [Related]
17. Cognitive impairment in older HIV-1-seropositive individuals: prevalence and potential mechanisms.
Valcour VG; Shikuma CM; Watters MR; Sacktor NC
AIDS; 2004 Jan; 18 Suppl 1(Suppl 1):S79-86. PubMed ID: 15075502
[TBL] [Abstract][Full Text] [Related]
18. The current understanding of overlap between characteristics of HIV-associated neurocognitive disorders and Alzheimer's disease.
Rubin LH; Sundermann EE; Moore DJ
J Neurovirol; 2019 Oct; 25(5):661-672. PubMed ID: 30671777
[TBL] [Abstract][Full Text] [Related]
19. HIV, aging, and cognition: emerging issues.
Valcour VG
Top Antivir Med; 2013; 21(3):119-23. PubMed ID: 23981600
[TBL] [Abstract][Full Text] [Related]
20. HIV-associated neurocognitive disorders: the relationship of HIV infection with physical and social comorbidities.
Tedaldi EM; Minniti NL; Fischer T
Biomed Res Int; 2015; 2015():641913. PubMed ID: 25815329
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
